Mankind Pharma Ltd.

NSE: MANKIND | BSE: 543904 | ISIN: INE634S01028 | Industry: Pharmaceuticals
| Expensive Performer
2224.3000 23.50 (1.07%)
NSE Jan 12, 2026 15:31 PM
Volume: 145.0K
 

2224.30
1.07%
Motilal Oswal
MANKIND has a strategic roadmap for growth through expansion in high entry barrier innovative product launches in the chronic/consumer segment and other adjacencies, transitioning from sexual wellness to consumer wellness in the over-the counter (OTC) space.
Number of FII/FPI investors decreased from 648 to 627 in Sep 2025 qtr
More from Mankind Pharma Ltd.
Recommended